Evidence map›Paper›PMID 40407876›Full record

ArticleInternational journal of legal medicine2025

Cardiac-specific troponin-I (cTnI) in a post-mortem setting.

Ethan D Sutton, Sarah Parsons, Maria Pricone, Hans H de Boer

Abstract read
In one paragraph

Article in International journal of legal medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ethan D SuttonBachelor of Biomedical Science Honours, School of Public Health and Preventive Medicine, Monash University, 553 St Kilda Road, Melbourne, VIC, 3004, Australia.
Sarah ParsonsDept. of Pathology, Victorian Institute of Forensic Medicine, 65 Kavanagh Street, Southbank, VIC, 3006, Australia.ORCID http://orcid.org/0000-0002-1238-1360
Maria PriconeDept. of Toxicology, Victorian Institute of Forensic Medicine, 65 Kavanagh Street, Southbank, VIC, 3006, Australia.
Hans H de BoerDept. of Pathology, Victorian Institute of Forensic Medicine, 65 Kavanagh Street, Southbank, VIC, 3006, Australia. hans.de.boer@vifm.org.ORCID http://orcid.org/0000-0001-8590-0945

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cardiac-specific troponin (cTn) is widely used in clinical medicine to support a diagnosis of acute myocardial infarction. Several studies have explored the value of cTn testing in deceased individuals. These studies suggest that -although there are important limitations associated with its use- post-mortem cTn can be useful in selected cases. A decision for post-mortem cTn testing should however be influenced by factors that have not been explored in much detail. This includes the success rate of post-mortem cTn testing, and whether cTn levels are stable after death.Therefore, this study addresses the post-mortem availability and stability of cardiac-specific Troponin I (cTnI). Post-mortem availability was determined by analysing the success rate in 250 high-sensitivity (hs-)cTnI tests on post-mortem blood samples, and its relationship with variables such as sample location, sample type, post-mortem interval, and decomposition. Post-mortem stability was explored by comparing post-mortem cTnI levels between two samples from the same individual, taken at different times.Post-mortem hs-cTnI tests were successful in 86.4% of cases (216/250), with little effect of sex, age, or cardiopulmonary resuscitation. Visible decomposition precluded a successful test. Other variables associated with decomposition (such as increased post-mortem interval) also affected test success negatively. Our results furthermore suggest that cTnI is very unstable post-mortem, with marked differences in hs-cTnI test results between samples from the same individual. The differences were large (on average 18734 ng/L) and not unidirectional. Instability appeared to increase with larger time intervals, but the results were overall erratic and difficult to interpret.We conclude that hs-cTnI testing results are generally available in a post-mortem setting, but that testing should be performed on the earliest available blood sample. Samples from decomposed individuals should not be tested. Furthermore, the severe instability of cTnI indicates that any post-mortem hs-cTnI result must be interpreted with caution.

Indexed as

Postmortem ChangesTroponin IAdultAgedAged, 80 and overAutopsyBiomarkersFemaleHumansMaleMiddle AgedMyocardial InfarctionYoung AdultBiomarkersTroponin IAutopsyBiochemistryBlood analysiscTnIDecompositionForensic medicinePathologySudden cardiac deathTroponin

Identifiers

PMID40407876
PMCPMC12354124

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.